Mein Warenkorb

Human Anti-RSV-F0 Antibody IgG Titer ELISA Assay Kit (Pre-Fusion glycoprotein F0)

User Reviews
Product Number/Spec
Price
Menge
RAS-T175-96tests
$770.00
ETA of in-stock products:2 business days
Gesamtanzahl Product Amount$ 0

Product Details

  • Materials Provided

    ID
    Components
    Size
    RAS175-C01
    Pre-coated Pre-Fusion glycoprotein F0 (RSV) Microplate
    1 plate
    RAS175-C02
    RSV-F0 Antibody Positive Control
    100 μL
    RAS175-C03
    RSV-F0 Antibody Negative Control
    100 μL
    RAS175-C04
    HRP-Conjugated Antibody
    50 μL
    RAS175-C05
    10 x Washing Buffer
    50 mL
    RAS175-C06
    Dilution Buffer
    50 mL
    RAS175-C07
    Substrate Solution
    12 mL
    RAS175-C08
    Stop Solution
    7 mL

  • Product Overview

    Human Anti-RSV-F0 Antibody IgG Titer ELISA Assay Kit (Pre-Fusion glycoprotein F0) is based on the indirect-ELISA method and is used to measure the Anti-RSV-F0 Antibody IgG (Pre-Fusion glycoprotein F0) titer in human serum. The kit is designed to provide a reliable solution for evaluating the immunogenicity during the clinical stage of RSV vaccine development.

  • Storage

    1. Unopened kit should be stored at 2℃-8℃ upon receiving.

    2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

    3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Kunden haben auch angesehen

User Reviews
Publish Comment

FAQ

  • Product

    What do “pre” and “post” refer to in the names of viral proteins?

    In virology, “pre” refers to the conformation of a viral surface glycoprotein before fusion with the host cell membrane, while “post” refers to the conformation after membrane fusion and entry into the host cell. Both are naturally occurring states in the viral life cycle. Because the “pre” conformation represents a critical stage before viral entry, antibodies designed against this state often exhibit stronger neutralizing activity and are therefore more effective in preventing infection.

Frontier Progress

 
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Kunden haben auch angesehen
  • User Reviews
  • FAQ
Kontaktieren Sie uns